News & events


24 December 2014

Cipla scoops state’s R2bn order to supply ARV drugs

Busines Report

CIPLA Medpro, South Africa’s third-biggest drugmaker, has won a R2 billion order to supply antiretroviral (ARV) drugs for the next three years to the government’s anti-Aids programme.

The medication to combat HIV will be made at a plant in KwaZulu-Natal under a contract that starts on April 1, Cape Town-based Cipla said yesterday.

Read the article online

Busines Report